药品注册申请号:016320
申请类型:NDA (新药申请)
申请人:STI PHARMA LLC
申请人全名:STI PHARMA LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 MYAMBUTOL ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 100MG Yes No AB 1967/11/06 Approved Prior to Jan 1, 1982 Prescription
002 MYAMBUTOL ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 200MG No No None Approved Prior to Jan 1, 1982 Discontinued
003 MYAMBUTOL ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 400MG Yes Yes AB Approved Prior to Jan 1, 1982 Prescription
004 MYAMBUTOL ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 500MG No No None Approved Prior to Jan 1, 1982 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2013/02/22 SUPPL-66(补充) Approval Manufacturing (CMC) PRIORITY
2008/10/30 SUPPL-63(补充) Approval Labeling STANDARD Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
2004/03/24 SUPPL-60(补充) Approval Labeling STANDARD
2003/02/06 SUPPL-58(补充) Approval Labeling STANDARD
2003/02/06 SUPPL-57(补充) Approval Labeling STANDARD
2001/10/10 SUPPL-56(补充) Approval Labeling STANDARD
1998/05/14 SUPPL-55(补充) Approval Manufacturing (CMC) PRIORITY
1998/05/08 SUPPL-54(补充) Approval Manufacturing (CMC) PRIORITY
1995/06/20 SUPPL-53(补充) Approval Manufacturing (CMC) PRIORITY
1987/11/23 SUPPL-51(补充) Approval Manufacturing (CMC) PRIORITY
1987/11/02 SUPPL-52(补充) Approval Manufacturing (CMC) PRIORITY
1987/06/25 SUPPL-46(补充) Approval Labeling
1987/05/19 SUPPL-50(补充) Approval Manufacturing (CMC) PRIORITY
1986/01/03 SUPPL-49(补充) Approval Manufacturing (CMC) PRIORITY
1985/09/12 SUPPL-47(补充) Approval Manufacturing (CMC) PRIORITY
1982/02/24 SUPPL-44(补充) Approval Manufacturing (CMC) PRIORITY
1981/11/03 SUPPL-43(补充) Approval Manufacturing (CMC) PRIORITY
1981/08/18 SUPPL-42(补充) Approval Manufacturing (CMC) PRIORITY
1981/08/18 SUPPL-41(补充) Approval Manufacturing (CMC) PRIORITY
1981/07/29 SUPPL-40(补充) Approval Manufacturing (CMC) PRIORITY
1981/01/09 SUPPL-39(补充) Approval Manufacturing (CMC) PRIORITY
1979/04/03 SUPPL-38(补充) Approval Manufacturing (CMC) PRIORITY
1979/04/03 SUPPL-37(补充) Approval Manufacturing (CMC) PRIORITY
1978/12/21 SUPPL-36(补充) Approval Labeling
1978/06/27 SUPPL-34(补充) Approval Manufacturing (CMC) PRIORITY
1978/06/26 SUPPL-35(补充) Approval Manufacturing (CMC) PRIORITY
1978/05/03 SUPPL-33(补充) Approval Manufacturing (CMC) PRIORITY
1978/04/07 SUPPL-32(补充) Approval Manufacturing (CMC) PRIORITY
1977/07/05 SUPPL-31(补充) Approval Manufacturing (CMC) PRIORITY
1977/05/13 SUPPL-30(补充) Approval Manufacturing (CMC) PRIORITY
1976/06/10 SUPPL-29(补充) Approval Manufacturing (CMC) PRIORITY
1976/04/28 SUPPL-28(补充) Approval Manufacturing (CMC) PRIORITY
1975/02/21 SUPPL-27(补充) Approval Manufacturing (CMC) PRIORITY
1967/11/06 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity PRIORITY
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ETHAMBUTOL HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:100MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
016320 001 NDA MYAMBUTOL ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 100MG Prescription Yes No AB Approved Prior to Jan 1, 1982 STI PHARMA LLC
075095 001 ANDA ETHAMBUTOL HYDROCHLORIDE ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 100MG Prescription No No AB 1999/11/30 EPIC PHARMA LLC
078939 001 ANDA ETHAMBUTOL HYDROCHLORIDE ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 100MG Prescription No No AB 2009/06/17 LUPIN
活性成分:ETHAMBUTOL HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:400MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
016320 003 NDA MYAMBUTOL ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 400MG Prescription Yes Yes AB Approved Prior to Jan 1, 1982 STI PHARMA LLC
075095 002 ANDA ETHAMBUTOL HYDROCHLORIDE ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 400MG Prescription No No AB 1999/11/30 EPIC PHARMA LLC
076057 001 ANDA ETHAMBUTOL HYDROCHLORIDE ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 400MG Discontinued No No AB 2001/11/26 BARR
078939 002 ANDA ETHAMBUTOL HYDROCHLORIDE ETHAMBUTOL HYDROCHLORIDE TABLET;ORAL 400MG Prescription No No AB 2009/06/17 LUPIN
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database